{{a.name}} - {{a.desc}} Tab/click for more specific Billable
Sorry, we weren't able to find any results that match your search. Try changing a word or two, or being a little more specific. Thanks!
ICD-10 E70.2 - Disorders of tyrosine metabolism

E70.2

ICD-10 Not billable

Disorders of tyrosine metabolism

Specifically for this code:
  • transitory tyrosinemia of newborn (P74.5)
From Section E70-E88:
  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • Ehlers-Danlos syndrome (Q79.6)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan's syndrome (Q87.4)
  • 5-alpha-reductase deficiency (E29.1)
From Chapter 4:
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
From Chapter 4:
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70.2 is a "category code," which means it's non-billable. Billable codes require more specificity. Use the list below to navigate to codes that are more specific:
10
E70.20
Disorder of tyrosine metabolism, unspecified
Billable
10
E70.21
Tyrosinemia
Billable
10
E70.29
Other disorders of tyrosine metabolism
Billable
      
Showing results for: {{searchResults.terms}}
More results: